Cargando…

Early Improvement in One Week Predicts the Treatment Response to Escitalopram in Patients with Social Anxiety Disorder: A Preliminary Study

OBJECTIVE: Social anxiety disorder (SAD) shows relatively delayed responses to pharmacotherapy when compared to other anxiety disorders. Therefore, more effective early therapeutic decisions can be made if the therapeutic response is predictable as early as possible. We studied whether the therapeut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oh, Kang-Seob, Shin, Eunsook, Ha, Juwon, Shin, Dongwon, Shin, Youngchul, Lim, Se-Won
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean College of Neuropsychopharmacology 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4857863/ https://www.ncbi.nlm.nih.gov/pubmed/27121427 http://dx.doi.org/10.9758/cpn.2016.14.2.161

Ejemplares similares

Comparison of Treatment Adherence between Selective Serotonin Reuptake Inhibitors and Moclobemide in Patients with Social Anxiety Disorder
por: Lim, Se-Won, et al.
Publicado: (2012)

The Relationship between Plasma Oxytocin Levels and Social Anxiety Symptoms
por: Oh, Kang-Seob, et al.
Publicado: (2018)

Resistant social anxiety disorder response to Escitalopram
por: Pallanti, Stefano, et al.
Publicado: (2006)

Lack of Association between Brain-Derived Neurotrophic Factor Gene Val66Met Polymorphisms and Generalized Social Anxiety Disorder in Korean Population
por: Park, Jin-Sung, et al.
Publicado: (2011)

Long-term administration of escitalopram in patients with social anxiety disorder in Japan
por: Asakura, Satoshi, et al.
Publicado: (2016)

Korean Guidelines for the Pharmacological Treatment of Social Anxiety Disorder: Initial Treatment Strategies
por: Yoon, Hyungkun, et al.
Publicado: (2018)

Safety and effectiveness of escitalopram in an 8-week open study in Chinese patients with depression and anxiety
por: Wang, Gang, et al.
Publicado: (2018)

Binge eating is associated with trait anxiety in Korean adolescent girls: a cross sectional study
por: Jung, Jin-Yi, et al.
Publicado: (2017)

One‐week escitalopram intake alters the excitation–inhibition balance in the healthy female brain
por: Zsido, Rachel G., et al.
Publicado: (2022)

Effects of Escitalopram on Anxiety in Patients with Acute Coronary Syndrome: A Randomized Controlled Trial
por: Kang, Hee-Ju, et al.
Publicado: (2017)

Efficacy and Safety of Escitalopram, Desvenlafaxine, and Vortioxetine in the Acute Treatment of Anxious Depression: A Randomized Rater-blinded 6-week Clinical Trial
por: Shin, Cheolmin, et al.
Publicado: (2023)

Efficacy of Buspirone Augmentation of Escitalopram in Patients with Major Depressive Disorder with and without Atypical Features: A Randomized, 8 Week, Multicenter, Open-Label Clinical Trial
por: Shin, Cheolmin, et al.
Publicado: (2020)

Pharmacotherapy and group cognitive behavioral therapy enhance follow-up treatment duration in gambling disorder patients
por: Choi, Sam-Wook, et al.
Publicado: (2016)

Efficacy and safety of generic escitalopram (Lexacure(®)) in patients with major depressive disorder: a 6-week multicenter, randomized, rater-blinded, escitalopram-comparative, non-inferiority study
por: Jeong, Jong-Hyun, et al.
Publicado: (2015)

Association of Hair Manganese Level with Symptoms in Attention-Deficit/Hyperactivity Disorder
por: Shin, Dong-Won, et al.
Publicado: (2015)

Serotonin and dopamine transporter availability in social anxiety disorder after combined treatment with escitalopram and cognitive-behavioral therapy
por: Hjorth, Olof, et al.
Publicado: (2022)

The Association between Physical Activity and Anxiety Symptoms for General Adult Populations: An Analysis of the Dose-Response Relationship
por: Kim, Sun-Young, et al.
Publicado: (2020)

PS85. Efficacy and Safety of Generic Escitalopram (Lexacure) in Patients with Major Depressive Disorder: A 6-week, Multi-center, Randomized, Rater-blinded, Escitalopram-comparative, Non-inferiority Study
por: Jeong, Jong-Hyun, et al.
Publicado: (2016)

Efficacy and tolerability of escitalopram in treatment of major depressive disorder with anxiety symptoms: a 24-week, open-label, prospective study in Chinese population
por: Jiang, Kaida, et al.
Publicado: (2017)

The Relationship between Serum Vitamin D Levels, C-Reactive Protein, and Anxiety Symptoms
por: Kim, Sun-Young, et al.
Publicado: (2020)

Do You Believe It? Verbal Suggestions Influence the Clinical and Neural Effects of Escitalopram in Social Anxiety Disorder: A Randomized Trial
por: Faria, Vanda, et al.
Publicado: (2017)

PS89. Influence of anxiety symptoms on improvement of neurocognitive functions in patients with major depressive disorder: A 12-week, multicenter, randomized trial of tianeptine versus escitalopram, the CAMPION study
por: Kim, Kiwon, et al.
Publicado: (2016)

Exercise and Escitalopram in the Treatment of Anxiety in Patients with Coronary Heart Disease: One Year Follow-Up of the UNWIND Randomized Clinical Trial
por: Blumenthal, James A., et al.
Publicado: (2022)

Escitalopram induced mania
por: Parker, Shubangi, et al.
Publicado: (2007)

Escitalopram in patients with psoriasis
por: Artemieva, M., et al.
Publicado: (2021)

Escitalopram Induced Angioedema
por: Conde, Samantha L, et al.
Publicado: (2022)

Gender Differences of Occupational Stress Associated with Suicidal Ideation among South Korean Employees: The Kangbuk Samsung Health Study
por: Kim, Sun-Young, et al.
Publicado: (2018)

Pharmacogenetically Guided Escitalopram Treatment for Pediatric Anxiety Disorders: Protocol for a Double-Blind Randomized Trial
por: Strawn, Jeffrey R., et al.
Publicado: (2021)

The therapeutic potential of escitalopram in the treatment of panic disorder
por: Townsend, Mark H, et al.
Publicado: (2007)

Economic evaluation of environmental epidemiological projects in national industrial complexes
por: Shin, Youngchul
Publicado: (2017)

Reproducibility of the Efficacy of Escitalopram in Patients with Major Depression Who Had Previously Remitted with Escitalopram
por: Yoshimura, Reiji, et al.
Publicado: (2021)

Association between Plasma Metabolic Profiles of the Antidepressant Escitalopram and Clinical Response in Subjects with Depression
por: Bandu, Raju, et al.
Publicado: (2023)

Analysis of health-related quality of life and costs based on a randomised clinical trial of escitalopram for relapse prevention in patients with generalised social anxiety disorder
por: François, C, et al.
Publicado: (2008)

What Kind of Stress Is Associated with Depression, Anxiety and Suicidal Ideation in Korean Employees?
por: Shin, Young-Chul, et al.
Publicado: (2017)

The genotoxicity of an aqueous extract of Gyejibokryeong-hwan
por: Lee, Mee-Young, et al.
Publicado: (2018)

The attention-emotion interaction in healthy female participants on oral contraceptives during 1-week escitalopram intake
por: Beinhölzl, Nathalie, et al.
Publicado: (2022)

A Multicenter, Prospective, Randomized, Parallel‐Group Trial on the Effects of Temporary Methotrexate Discontinuation for One Week Versus Two Weeks on Seasonal Influenza Vaccination in Patients With Rheumatoid Arthritis
por: Park, Jin Kyun, et al.
Publicado: (2022)

Interaction between escitalopram and risperidone
por: Rao, Pradeep, et al.
Publicado: (2005)

Severe hyponatremia associated with escitalopram
por: Rawal, Gautam, et al.
Publicado: (2017)

Escitalopram-induced extrapyramidal symptoms
por: Kumar, Pattath Narayanan Suresh, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qmt511g23dnet266s3tgp41o1i